Sulochana R. Gawande

Phase III Trial of Gemcitabine Plus Carboplatin Versus Single-Agent Gemcitabine in the Treatment of Locally Advanced or Metastatic Non–Small-Cell Lung Cancer: The Swedish Lung Cancer Study Group

Christer Sederholm, Gunnar Hillerdal, Kristina Lamberg et al. · Journal of Clinical Oncology · 2005 · 215 citations · Full text

Medicine, Oncology, Pharmacology +15

Patient-reported health status in total joint replacement

Robert Benroth, Sulochana R. Gawande · The Journal of Arthroplasty · 1999 · 48 citations

Medicine, Orthopaedic Surgery, Orthopedic Surgery +14

First-line therapy with gemcitabine and paclitaxel in locally, recurrent or metastatic breast cancer: A phase II study

Djelila Allouache, Sulochana R. Gawande, M. Tubiana-Hulin et al. · BMC Cancer · 2005 · 27 citations · Full text

Medicine, Oncology, Pharmacology +17

A window of opportunity phase II study of enzastaurin in chemonaive patients with asymptomatic metastatic colorectal cancer

Bengt Glimelius, Michael Lahn, Sulochana R. Gawande et al. · Annals of Oncology · 2009 · 25 citations

Medicine, Oncology, Pharmacotherapy +10

Optimized sequence of drug administration and schedule leads to improved dose delivery for gemcitabine and paclitaxel in combination: a phase I trial in patients with recurrent ovarian cancer

C. Poole, Timothy Perren, Sulochana R. Gawande et al. · International Journal of Gynecological Cancer · 2006 · 10 citations

Medicine, Oncology, Pharmacology +17